Although the year 2020 was a trying one in so many ways, one bright spot that we at CFIF repeatedly…
CFIF on Twitter CFIF on YouTube
Image of the Day: Medical / Pharmaceutical / Healthcare Sector Approval Skyrockets

Although the year 2020 was a trying one in so many ways, one bright spot that we at CFIF repeatedly highlighted is the wondrous way in which America's pharmaceutical sector came to the rescue, achieving in one year what typically takes a decade or more:  devising and perfecting not one, but multiple lifesaving vaccines.  It's therefore no surprise, but welcome nonetheless, that Americans' approval of our healthcare sector and its workers skyrocketed.  Their remarkable achievements have not gone unnoticed:

[caption id="" align="alignleft" width="625"] Medical Sector Approval Skyrocketed[/caption]

 …[more]

January 04, 2021 • 11:09 AM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Jester's CourtroomLegal tales stranger than stranger than fiction: Ridiculous and sometimes funny lawsuits plaguing our courts.
Using Lifesaving Drugs as a Means of Redistribution Print
By Betsy McCaughey
Wednesday, July 29 2020
The ICU is no place for social engineering.

When lifesaving drugs run low, hospitals have to choose which patients get a scarce drug, while others go without. Some even die. Historically, medical ethicists have recommended giving the drug to the patient most likely to benefit or using a lottery to give every patient an equal chance. 

Not any more. Pennsylvania hospitals are tilting the scale in favor of patients from "disadvantaged areas." If you're middle class, you're toast. 

To "redress social injustices," Pennsylvania is applying a "weighted lottery" statewide, to hike the odds that the scarce drug remdesivir for COVID-19 will be given to patients from poor neighborhoods in preference to other patients. 

Remdesivir is a medicine that speeds recovery and, according to its maker, Gilead Sciences, increases survival by 62%. 

If you can get it. Your ZIP code could literally mean the difference between life and death.

"This is all very new," explains Douglas White, an ethicist at the University of Pittsburgh, who helped devise the weighted lottery. 

Some medical ethicists are urging that other states follow suit. South Carolina reports that if remdesivir runs short there, the state will apply preferences like UPMC's lottery, according to Dee Ford, professor at the Medical University of South Carolina who helped design the South Carolina approach. 

The public needs to speak out before this deadly scheme comes to their state.

In the past, if many patients needed a scarce drug, deciding who got it involved only their medical conditions. That's consistent with the American Medical Association guidelines  that the patient most likely to benefit medically from the drug should get it. 

It's a far cry from favoring patients from low-income ZIP codes. 

The Greenwall Foundation, a medical ethics group, advocates "mitigating health disparities" by prioritizing who gets remdesivir and future COVID-19 therapeutics. So do researchers at the University of California, San Francisco. 

This isn't just about remdesivir. Giving medical preferences to the economically disadvantaged is gaining steam. The Organ Procurement and Transplantation Network floated a proposal in January to require transplant candidates to provide household income on their applications, as a first step toward increasing the number of transplants offered to patients with low "socioeconomic status." It's provoked considerable controversy from other transplant advocacy groups. 

Academics are using the pandemic as a launching pad to push their redistributionist agenda. But it's not what the public believes is morally right. A majority of people say a hospital's goals should be saving the most lives and treating people equally, according to a June 2020 poll. 

Many physicians agree. Downstate Medical Center cardiologist Jeffrey Borer says, "a means test in either direction is unethical." 

New York has so few COVID-19 hospitalized patients that it recently sent remdesivir to Florida. Texas is reserving its supply for patients not yet on ventilators. Minnesota emphatically rejects socioeconomic preferences. 

Most states are not rigging the system  yet. But it's likely to spread fast if left up to university medical ethicists, who are trying to keep it quiet. Families won't know if their ZIP code had something to do with why Dad died in the ICU. 

The Pennsylvania lottery's designers say they were inspired by a weighted lottery for oversubscribed charter schools that gave preferences based on address. 

That should be a warning. Preferential admissions have roiled the nation. Preferential treatment in hospitals, where it could determine who survives, would be even more divisive.

On the other hand, it's common sense that when a COVID-19 vaccine becomes available, it should be distributed to disadvantaged neighborhoods first to prevent the most cases. Residents there are more likely to live in crowded conditions, unable to socially distance, and to work on jobs in mass transit and grocery stores that expose them to the disease. 

But caring for hospital patients is a different matter. Equal treatment is the only morally acceptable rule. 

Patients need to trust that their caregivers are doing all they can. The ICU is no place for social engineering. Preferential treatment there is frightening. The public needs to stop it now. 


Betsy McCaughey is chairman of the Committee to Reduce Infection Deaths and a former lieutenant governor of New York. 

COPYRIGHT 2020 CREATORS.COM

Question of the Week   
Which one of the following was eulogized as “First in war, first in peace, and first in the hearts of his countrymen”?
More Questions
Quote of the Day   
 
"The irony of the Squad's fame contributing to Democrats' losses is that their party's weakness empowers them. As the moderate wing of the Democratic Party has thinned, the progressive contingent has grown in strength. Of the 15 incoming Democratic freshmen, eight are members of the Congressional Progressive Caucus and two -- Cori Bush from Missouri, a 'racial justice activist' who wants to 'defund…[more]
 
 
—David Harsanyi, National Review Senior Writer
— David Harsanyi, National Review Senior Writer
 
Liberty Poll   

Thinking only of your local circumstances, are coronavirus vaccinations proceeding about as well as can be expected given the task at hand, or subject to serious problems?